TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia.

Anjali S Advani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.